Valeo Financial Advisors, LLC

Position in VCEL — Vericel Corp

CIK 1722641 CARMEL, IN

Position in VCEL

as of Jun 30, 2026 · filed Jul 8, 2026 Compact

Position Value

$413,267

+$117,464 QoQ

Shares Held

9,289

+1.0% QoQ

Ownership

0.018%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#187

of 315 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Valeo Financial Advisors, LLC holds $6,495,341 across 14 Biotechnology names. VCEL ranks #6 (6.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,787	$1,881,116
2	ARGX	Argenx SE	1,077	$999,208
3	REGN	Regeneron Pharmaceuticals, Inc.	1,289	$803,743
4	RLAY	Relay Therapeutics, Inc.	35,687	$667,703
5	MRNA	Moderna, Inc.	7,412	$519,062
6	VCEL	Vericel Corp This page	9,289	$413,267
7	TGTX	Tg Therapeutics, Inc.	6,033	$331,453
8	TARS	Tarsus Pharmaceuticals, Inc.	3,838	$241,563

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$413,267	9,289	+1.0%	Shares	Sole	2026-07-08
2026-03-31	$295,803	9,195	-19.9%	Shares	Sole	2026-05-08
2025-12-31	$413,574	11,485	+0.3%	Shares	Sole	2026-02-04
2025-09-30	$360,205	11,446	+11.1%	Shares	Sole	2025-11-03
2025-06-30	$438,265	10,300	+11.1%	Shares	Sole	2025-09-12
2025-03-31	$413,805	9,274	+26.3%	Shares	Sole	2025-04-30
2024-12-31	$403,204	7,343	-19.7%	Shares	Sole	2025-01-30
2024-09-30	$386,545	9,149	+914800.0%	Shares	Sole	2024-10-10
2021-03-31	$55	1	0.0%	Shares	Sole	2021-04-12
2020-12-31	$30	1	0.0%	Shares	Sole	2021-02-11
2020-09-30	$18	1	0.0%	Shares	Sole	2020-10-28
2020-06-30	$13	1	0.0%	Shares	Sole	2020-07-20
2020-03-31	$9	1	—	Shares	Sole	2020-04-13
No filing history on record for this holder in this stock.